The unclear prognostic significance of IDH mutations may be due to the vast heterogeneity of co-occurring mutations and the various locations where they may occur, making genetic profiling and translational research essential in clarifying the role of IDH in AML. Here, IDH1 is linked to acute myeloid leukemia.